BlackRock’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $308M | Buy |
8,478,815
+490,267
| +6% | +$21.9M | 0.01% | 1425 |
|
|
2025
Q4 | $372M | Buy |
7,988,548
+401,951
| +5% | +$17.9M | 0.01% | 1299 |
|
|
2025
Q3 | $316M | Buy |
7,586,597
+167,882
| +2% | +$5.37M | 0.01% | 1373 |
|
|
2025
Q2 | $213M | Sell |
7,418,715
-237,854
| -3% | -$7.35M | ﹤0.01% | 1590 |
|
|
2025
Q1 | $257M | Buy |
7,656,569
+141,376
| +2% | +$5.28M | 0.01% | 1449 |
|
|
2024
Q4 | $384M | Buy |
7,515,193
+965,251
| +15% | +$54M | 0.01% | 1252 |
|
|
2024
Q3 | $335M | Buy |
6,549,942
+319,571
| +5% | +$16.5M | 0.01% | 1351 |
|
|
2024
Q2 | $279M | Buy |
6,230,371
+794,267
| +15% | +$36.7M | 0.01% | 1396 |
|
|
2024
Q1 | $254M | Buy |
5,436,104
+90,990
| +2% | +$3.56M | 0.01% | 1484 |
|
|
2023
Q4 | $190M | Buy |
5,345,114
+499,397
| +10% | +$15.3M | ﹤0.01% | 1680 |
|
|
2023
Q3 | $144M | Buy |
4,845,717
+245,231
| +5% | +$5.05M | ﹤0.01% | 1767 |
|
|
2023
Q2 | $82.9M | Buy |
4,600,486
+644,128
| +16% | +$12.8M | ﹤0.01% | 2169 |
|
|
2023
Q1 | $63.5M | Buy |
3,956,358
+38,869
| +1% | +$719K | ﹤0.01% | 2289 |
|
|
2022
Q4 | $71.7M | Buy |
3,917,489
+165,467
| +4% | +$2.92M | ﹤0.01% | 2231 |
|
|
2022
Q3 | $73.7M | Sell |
3,752,022
-37,461
| -1% | -$764K | ﹤0.01% | 2160 |
|
|
2022
Q2 | $70.7M | Buy |
3,789,483
+492,703
| +15% | +$9.83M | ﹤0.01% | 2256 |
|
|
2022
Q1 | $72.4M | Buy |
3,296,780
+20,610
| +0.6% | +$417K | ﹤0.01% | 2348 |
|
|
2021
Q4 | $93.1M | Buy |
3,276,170
+659,331
| +25% | +$16.3M | ﹤0.01% | 2258 |
|
|
2021
Q3 | $55.1M | Buy |
2,616,839
+23,453
| +0.9% | +$491K | ﹤0.01% | 2598 |
|
|
2021
Q2 | $48.9M | Buy |
2,593,386
+426,878
| +20% | +$7.5M | ﹤0.01% | 2721 |
|
|
2021
Q1 | $33.1M | Buy |
2,166,508
+53,313
| +3% | +$826K | ﹤0.01% | 2889 |
|
|
2020
Q4 | $29.8M | Buy |
2,113,195
+314,497
| +17% | +$4.38M | ﹤0.01% | 2798 |
|
|
2020
Q3 | $28.2M | Buy |
1,798,698
+30,829
| +2% | +$471K | ﹤0.01% | 2667 |
|
|
2020
Q2 | $31M | Buy |
1,767,869
+1,045,566
| +145% | +$17.8M | ﹤0.01% | 2558 |
|
|
2020
Q1 | $10.6M | Sell |
722,303
-9,752
| -1% | -$200K | ﹤0.01% | 2959 |
|
|
2019
Q4 | $18.4M | Sell |
732,055
-231,947
| -24% | -$4.42M | ﹤0.01% | 2928 |
|
|
2019
Q3 | $14.5M | Buy |
964,002
+31,578
| +3% | +$614K | ﹤0.01% | 3001 |
|
|
2019
Q2 | $23.3M | Buy |
932,424
+154,450
| +20% | +$3.82M | ﹤0.01% | 2766 |
|
|
2019
Q1 | $17.7M | Buy |
777,974
+84,802
| +12% | +$2.08M | ﹤0.01% | 2810 |
|
|
2018
Q4 | $20.8M | Buy |
693,172
+273,886
| +65% | +$7.71M | ﹤0.01% | 2702 |
|
|
2018
Q3 | $12M | Buy |
+419,286
| New | +$12.4M | ﹤0.01% | 3144 |
|
Other funds holding CRNX
FCM
DCM
VCM
VPM
EC
BG